Tech Focus Guyana: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Focus Guyana.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on January 8, 2026

Jan. 8, 2026

Open Campus partners with government of Madhya Pradesh and Geeks of Gurukul to digitize 50 million academic records

GlobeNewswire

Jan. 8, 2026

Orion Pharma announces the initiation of TEADES Phase 2 trial of ODM-212 in Malignant Pleural Mesothelioma (MPM) and Epithelioid Hemangioendothelioma (EHE)

GlobeNewswire

Jan. 8, 2026

Agomab Announces Positive Phase 1 Interim Results with AGMB-447 in Healthy Participants and Initiation of Idiopathic Pulmonary Fibrosis Cohort

GlobeNewswire

Jan. 8, 2026

Orion Pharma on aloittanut ODM-212-molekyylillä TEADES Faasi 2 -tutkimuksen pahanlaatuisen keuhkopussin mesoteliooman (MPM) ja epitelioidi hemangioendoteliooman (EHE) hoidossa

GlobeNewswire

Jan. 8, 2026

B2PRIME Integrates with TradingView and Becomes Its Platinum Partner to Deliver Seamless Charting and Trade Execution

GlobeNewswire

Jan. 8, 2026

Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference

GlobeNewswire

Jan. 8, 2026

EnteroBiotix announces positive Phase 2 TrIuMPH results supporting EBX-102-02 as a potential first-in-class, oral, full-spectrum microbiome therapy for irritable bowel syndrome

GlobeNewswire

Jan. 8, 2026

Rakovina Therapeutics and Variational AI Expand Collaboration to Advance Next-Generation ATR Inhibitors

GlobeNewswire

Jan. 8, 2026

Wery AI Launches All-in-One Creative Suite to Simplify Professional Content Creation

GlobeNewswire

Jan. 8, 2026

Engitix Announces $25 Million Series A Extension Financing by Existing Investor Mike Platt to Advance ECM-Targeted Therapeutics in Solid Tumors and Fibrosis

GlobeNewswire

Jan. 8, 2026

PathAI and University Hospital Zurich Announce Collaboration to Deploy AISight® Dx and AIM-TumorCellularity for Routine Molecular Pathology Workflows

GlobeNewswire

Jan. 8, 2026

Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics

GlobeNewswire

Jan. 8, 2026

Nxera Pharma Licenses Japan and Select Asia-Pacific Rights to Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals

GlobeNewswire

Jan. 8, 2026

Santhera lizenziert AGAMREE® (Vamorolon) an Nxera Pharma in Japan, Südkorea, Australien und Neuseeland im Rahmen eines Vertrags mit einem Wert von bis zu 205 Millionen US-Dollar zuzüglich Lizenzgebühren

GlobeNewswire

Jan. 8, 2026

Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties

GlobeNewswire

Jan. 8, 2026

Tensive reports positive pivotal trial top-line results showing REGENERA™ bioresorbable device may transform breast reconstruction

GlobeNewswire

Jan. 8, 2026

Eleva appoints Erich Rajkovic as new Chief Business Officer

GlobeNewswire

Jan. 8, 2026

TomTom and Visteon Partner to Launch In-Car AI: Privacy-First, Onboard Conversational Navigation

GlobeNewswire

Jan. 8, 2026

TomTom enhances maps and navigation with Microsoft Azure integration

GlobeNewswire

Jan. 8, 2026

Basilea informiert über Stand seines Portfolios und gibt Ausblick

GlobeNewswire